Calcium carbonate-calcium phosphate mixed cement compositions for bone reconstruction

被引:50
作者
Combes, C.
Bareille, R.
Rey, C.
机构
[1] ENSIACET, CIRMAT, CNRS, UMR5085,Equipe Phys Chim Phosphates, F-31077 Toulouse 4, France
[2] Univ Bordeaux 2, INSERM, Lab Biomat & Reparat Tissulaire, U577, F-33076 Bordeaux, France
关键词
bone cement; calcium carbonate; calcium phosphate; FTIR spectroscopy; cytotoxicity;
D O I
10.1002/jbm.a.30795
中图分类号
R318 [生物医学工程];
学科分类号
0831 [生物医学工程];
摘要
The feasibility of making calcium carbonate-calcium phosphate (CaCO3-CaP) mixed cements, comprising at least 40% (w/w) CaCO3 in the dry powder ingredients, has been demonstrated. Several original cement compositions were obtained by mixing metastable crystalline CaCO3 phases with metastable amorphous or crystalline CaP powders in aqueous medium. The cements set within at most 1 h at 37 degrees C in atmosphere saturated with water. The hardened cement is microporous and exhibits weak compressive strength. The setting reaction appeared to be essentially related to the formation of a highly carbonated nanocrystalline apatite phase by reaction of the metastable CaP phase with part or almost all of the metastable CaCO3 phase. The recrystallization of metastable CaP varieties led to a final cement consisting of a highly carbonated poorly crystalline apatite analogous to bone mineral associated with various amounts of vaterite and/or aragonite. The presence of controlled amounts of CaCO3 with a higher solubility than that of the apatite formed in the well-developed CaP cements might be of interest to increase resorption rates in biomedical cement and favors its replacement by bone tissue. Cytotoxicity testing revealed excellent cytocompatibility of CaCO3-CaP mixed cement compositions. (c) 2006 Wiley Periodicals, Inc.
引用
收藏
页码:318 / 328
页数:11
相关论文
共 63 条
[1]
[Anonymous], [No title captured], Patent No. 2830249
[2]
[Anonymous], ACTUALITES BIOMATERI
[3]
[Anonymous], [No title captured], Patent No. 6117456
[4]
Osteogenesis with coral is increased by BMP and BMC in a rat cranioplasty [J].
Arnaud, E ;
De Pollak, C ;
Meunier, A ;
Sedel, L ;
Damien, C ;
Petite, H .
BIOMATERIALS, 1999, 20 (20) :1909-1918
[5]
Interface between bone and nacre implants in sheep [J].
Atlan, G ;
Delattre, O ;
Berland, S ;
LeFaou, A ;
Nabias, G ;
Cot, D ;
Lopez, E .
BIOMATERIALS, 1999, 20 (11) :1017-1022
[6]
Transforming growth factor-beta 1 incorporation in a calcium phosphate bone cement: Material properties and release characteristics [J].
Blom, EJ ;
Klein-Nulend, J ;
Wolk, JGC ;
van Waas, MAJ ;
Driessens, FCM ;
Burger, EH .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 2002, 59 (02) :265-272
[7]
Characterization of the trabecular rat bone mineral: Effect of ovariectomy and bisphosphonate treatment [J].
Bohic, S ;
Rey, C ;
Legrand, A ;
Sfihi, H ;
Rohanizadeh, R ;
Martel, C ;
Barbier, A ;
Daculsi, G .
BONE, 2000, 26 (04) :341-348
[8]
New hydraulic cements based on α-tricalcium phosphate-calcium sulfate dihydrate mixtures [J].
Bohner, M .
BIOMATERIALS, 2004, 25 (04) :741-749
[9]
Bohner M, 2000, Injury, V31 Suppl 4, P37
[10]
Resorption kinetics of osseous substitute: Natural coral and synthetic hydroxyapatite [J].
Braye, F ;
Irigaray, JL ;
Jallot, E ;
Oudadesse, H ;
Weber, G ;
Deschamps, N ;
Deschamps, C ;
Frayssinet, P ;
Tourenne, P ;
Tixier, H ;
Terver, S ;
Lefaivre, J ;
Amirabadi, A .
BIOMATERIALS, 1996, 17 (13) :1345-1350